Technical Analysis for ABEO - Abeona Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.20 | -0.94% | -0.04 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | -0.94% | |
| Bollinger Band Squeeze | Range Contraction | -0.94% | |
| BB Squeeze + Lower Band Touch | Range Contraction | -0.94% | |
| Inside Day | Range Contraction | -0.94% | |
| Lower Bollinger Band Touch | Weakness | -0.94% | |
| Oversold Stochastic | Weakness | -0.94% |
| Alert | Time |
|---|---|
| Down 1% | about 8 hours ago |
| Up 2% | about 8 hours ago |
| 60 Minute Opening Range Breakdown | about 8 hours ago |
| Up 1% | about 10 hours ago |
| Rose Above Previous Day's High | about 10 hours ago |
Get a Trading Sidekick!
- Earnings date: 08/06/2024
Abeona Therapeutics Inc. Description
Abeona Therapeutics, Inc., formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for severe and rare diseases. The Company's lead program includes adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB). Its product pipeline includes ABO-101 (sc AAV9 NAGLU), which is used for the treatment of MPS III B; ABO-102 (sc AAV9 SGSH), which is used for the treatment of MPS III A; ABO-201 (sc AAV9 CLN3), which is used for the treatment of Juvenile Batten Disease (JBD); ABO-301 (AAV LK19 FANCC), which is used for the treatment of Fanconi Anemia (FA), and clustered, regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) gene editing, which is used for treatment of other rare blood diseases. The Company offers two platforms: Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT).
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Biology Emerging Technologies Molecular Biology Rare Diseases Gene Therapy Genetics Genetic Engineering Anemia CRISPR Genome Editing Adeno Associated Virus Cas9 Severe And Rare Diseases Blood Diseases Fanconi Anemia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.01 |
| 52 Week Low | 2.85 |
| Average Volume | 857,852 |
| 200-Day Moving Average | 5.18 |
| 50-Day Moving Average | 4.37 |
| 20-Day Moving Average | 4.40 |
| 10-Day Moving Average | 4.34 |
| Average True Range | 0.27 |
| RSI (14) | 42.53 |
| ADX | 11.63 |
| +DI | 18.64 |
| -DI | 17.89 |
| Chandelier Exit (Long, 3 ATRs) | 4.01 |
| Chandelier Exit (Short, 3 ATRs) | 4.85 |
| Upper Bollinger Bands | 4.70 |
| Lower Bollinger Band | 4.09 |
| Percent B (%b) | 0.18 |
| BandWidth | 13.87 |
| MACD Line | -0.10 |
| MACD Signal Line | -0.10 |
| MACD Histogram | -0.0067 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.42 | ||||
| Resistance 3 (R3) | 4.44 | 4.38 | 4.38 | ||
| Resistance 2 (R2) | 4.38 | 4.32 | 4.37 | 4.37 | |
| Resistance 1 (R1) | 4.29 | 4.29 | 4.26 | 4.27 | 4.36 |
| Pivot Point | 4.24 | 4.24 | 4.22 | 4.23 | 4.24 |
| Support 1 (S1) | 4.15 | 4.18 | 4.12 | 4.13 | 4.04 |
| Support 2 (S2) | 4.09 | 4.15 | 4.08 | 4.03 | |
| Support 3 (S3) | 4.00 | 4.09 | 4.02 | ||
| Support 4 (S4) | 3.98 |
